Volume 10, Number 6 (Aug 2019)

Editorial

2019 ASCO Annual Meeting: Takeaways for Advanced Practitioners

Editor-in-Chief Pamela Hallquist Viale, RN, MS, CNS, ANP, introduces the first JADPRO issue offering coverage of the most important research presented at the ASCO Annual Meeting.

August 21, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Gastrointestinal Cancer

Using coverage from The ASCO Post of the ASCO Annual Meeting, Carolyn Grande, CRNP, AOCNP®, of the University of Pennsylvania Health System evaluates study findings in gastrointestinal cancer and discusses what advanced practitioners sho...

August 22, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Prostate Cancer

Following coverage by The ASCO Post, Jennifer L. Glass, PA-C, MS, of the Mayo Clinic dives into the major findings in prostate cancer from the 2019 ASCO Annual Meeting in Chicago and their implications for advanced practitioners.

August 26, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Genitourinary (Non-Prostate) Cancers

Jeannette Hammond, PA-C, of the Seattle Cancer Care Alliance comments on major research presented at the ASCO Annual Meeting: a study addressing an unmet need in the metastatic urothelial cancer setting, a study showing no benefit from a...

August 22, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Gynecologic Cancers

Laura Doherty, FNP-BC, AOCNP®, of the Women & Infants Hospital of Rhode Island offers commentary on major gynecologic cancer abstracts featured from the ASCO Annual Meeting by The ASCO Post, including findings in carcinosarcoma of th...

August 22, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Breast Cancer

Wendy H. Vogel, MSN, FNP, AOCNP®, of Wellmont Cancer Institute discusses results from a study in hormone receptor–positive metastatic breast cancer (MONALEESA-7), two studies in the metastatic HER2-positive setting (SOPHIA and NALA), as ...

August 21, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Non–Small Cell Lung Cancer

Options for patients with non–small cell lung cancer have expanded following trials studying the safety and efficacy of checkpoint inhibitors and targeted therapies. Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, of MD Anderson Cancer Cent...

August 26, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Melanoma

In recent years, there has been an explosion of therapies for the treatment of melanoma, including BRAF mutation–guided therapy. With coverage by The ASCO Post, Lisa Kottschade, APRN, MSN, CNP, of the Mayo Clinic reviews clinical data su...

August 26, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Other Solid Cancers

Trials studying additional solid cancers, such as pancreatic cancer, head and neck cancer, glioblastoma, and glioma are reviewed in this section and accompanied by advanced practitioner commentaries. In addition, a study exploring the be...

August 26, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Hematologic Malignancies

Amy Pierre, MSN, ANP-BC, of the Memorial Sloan Kettering Cancer Center, and Nancy M. Nix, PharmD, BCPS, BCOP of St. Joseph’s/Candler Health System offer an advanced practitioner perspective on trials assessing the efficacy and safety of ...

August 22, 2019

Meeting Report

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Issues in Oncology

Several abstracts presented at the ASCO Annual Meeting reflected the meeting theme of providing high-quality care to every patient. Following coverage by The ASCO Post, Editor-in-Chief to JADPRO, Pamela Hallquist Viale, RN, MS, CNS, ANP,...

August 26, 2019